How a CHRO Turned Toxic Leadership Into 2025 Profitability
TALES FROM THE LEADERSHIP FRONT
Maya stepped into 2025 as CHRO of a 5,000‑person pharmaceutical company with a clear mandate: improve profitability without burning people out. Her biggest constraint wasn’t the market; it was the cost of toxic and misaligned leaders quietly eroding performance, engagement, and retention at the top.